HemoBioTech, Inc. announced today that Arthur Bollon, Ph.D., Chairman and Chief Executive Officer of HemoBioTech, will be presenting at the nanoTX '07 Conference and Expo in Dallas, Texas on October 3, 2007.
According to a recently published BCC Research report, the global market for nanofibers increased from $40.2 million in 2005 to $43.2 million in 2006 with sales reaching an estimated $48.0 million by the end of 2007. It should reach $176 million in 2012.
Malvern Instruments exhibits the Zetasizer Nano particle and molecular characterization system at L.A.B. (October 2-4, 2007, ExCeL, London, UK) and will also introduce visitors to the latest additions to the company's range of particle characterization, rheology and chemical imaging systems.
Nanogen, Inc., developer of advanced diagnostic products, announced today that it has been granted United States Patent No. 7,252,940, titled "Abasic site endonuclease assay" from the U.S. Patent and Trademark Office.